Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05605496 |
| Title | A Multicenter, Open-label, Proof of Concept Phase II Aiming to Assess the Clinical and Biological Activity of Anti-netrin-1 (NP137) as Add on Therapy in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Immunotherapies (IMMUNONET) |
| Acronym | IMMUNONET |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Centre Leon Berard |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Centre Léon Bérard | Lyon | 69008 | France | Details | ||
| Centre Antoine Lacassagne | Nice | 06189 | France | Details | ||
| Institut Curie | Paris | 75005 | France | Details | ||
| Institut de Cancérologie Strasbourg Europe (ICANS) | Strasbourg | 67033 | France | Details | ||
| Institut Claudius Regaud (IUCT Oncopole) | Toulouse | 31059 | France | Details |